Medicare Advantage and Part D Final Rule Affects Marketing and Sales Landscape for Not Only MA Plans and PD Sponsors, but also TPMOs and FDRs

• April 25, 2023

• Jana Kolarik , Foley & Lardner LLP

In a prior article, my colleagues Judith Waltz and Alexandra Shalom summarized the takeaways related to health equity and utilization management provisions from the Centers for Medicare and Medicaid Services (CMS) Final Rule that amended regulations for Medicare Advantage (MA or Part C), Medicare Cost Plan, the Medicare Prescription Drug Benefit (Part D) programs, and Programs of All-Inclusive Care for the Elderly (PACE). The Final Rule was published on April 12, 2023. This article focuses on the changes to the Medicare Advantage (MA) and Part D programs marketing rules at 42 C.F.R. parts 422 and 423, which are applicable for all contract year 2024 marketing and communications beginning September 30, 2023:

ARTICLE TAGS

• Regulation, Accreditation, and Payment Practice Group
• Government Reimbursement